Evidence map›Paper›PMID 15553310›Full record

Trial reportClinical cardiology2004

Characteristics of contemporary patients with hypertension and coronary artery disease.

Rhonda M Cooper-DeHoff, Eileen M Handberg, Jerome Cohen, Peter Kowey, Franz H Messerli, Giuseppe Mancia, Jose L Cangiano, Efrain Gaxiola, David Garcia-Barreto, Ann C Hewkin and 2 more

Registry-linked trialOpen access · bronzeAbstract readClinical TrialComparative StudyMulticenter Study
In one paragraph

Trial report in Clinical cardiology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00133692 (INternational VErapamil SR Trandolapril STudy), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00133692 phase4completednot on this map

INternational VErapamil SR Trandolapril STudy

TypeinterventionalSponsorUniversity of FloridaRan1997 to 2003Enrolled22,000ConditionsHypertension, Coronary Artery DiseaseArmsVerapamil SR/Trandolapril/Hydrochlorothiazide (HCTZ), Atenolol/HCTZ/Trandolapril
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 4 countries.

Rhonda M Cooper-DeHoffDivision of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida 32610-0277, USA. dehofrm@medicine.ufl.edu
Eileen M Handberg
Jerome Cohen
Peter Kowey
Franz H Messerli
Giuseppe Mancia
Jose L Cangiano
Efrain Gaxiola
David Garcia-Barreto
Ann C Hewkin
Carl J Pepine
INVEST Investigators
Florida College · USAbbott Fund · USInstituto de Cardiología y Cirugía Cardiovascular · CUInstituto Jalisciense de Cancerología · MXLankenau Medical Center · USOchsner Medical Center · USSaint Louis University · USUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite a high prevalence of hypertension in the population with CAD, there are limited data describing the clinical characteristics and treatments, as well as their interrelations in these patients. This is particularly true for black and Hispanic patients who have been underrepresented in randomized CAD trials. HYPOTHESIS: There exist racial and ethnic differences that define the characteristics of patients with both coronary artery disease (CAD) and hypertension.

methodsThis report describes the characteristics of Caucasian, Hispanic, and black patients enrolled in the International Verapamil SR/trandolapril Study (INVEST), a prospective trial undertaken exclusively in patients with CAD and hypertension.

resultsIn all, 10,925 Caucasian, 8,045 Hispanic, and 3,029 black patients are described. An abnormal angiogram or documented myocardial infarction was observed more frequently in Caucasian patients (73%), while angina pectoris was more prevalent in Hispanic patients (87%). Diabetes and left ventricular hypertrophy were most common in black patients (33 and 29%, respectively), while hypercholesterolemia and prior revascularization (coronary artery bypass graft or angioplasty) were most common in Caucasian patients (64 and 41%, respectively). More than 60% of Hispanic and black patients were women--a unique characteristic for randomized CAD trials. Comparing race/ethnic cohorts, there were significant differences for all characteristics. More than 80% of patients in all race/ethnic groups were receiving antihypertensive therapy; however, only fewer than 25% had controlled blood pressure according to guidelines from the sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure.

conclusionsThis high-risk population of hypertensive patients with CAD has been undertreated and does not have well-controlled BP. Race/ethnic differences were observed for clinical characteristics and medication use.

Indexed as

AgedAmericasAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsAsian PeopleAustraliaBlack PeopleBlood PressureCoronary AngiographyCoronary Artery DiseaseEuropeFemaleHispanic or LatinoHumansHypertensionHypertrophy, Left VentricularAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsHypolipidemic Agents

Identifiers

PMID15553310
PMCPMC6654359
OpenAlexW1535675136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.